Clinical Trial Update: Biological Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a biological therapy for myelodysplastic syndromes has completed, with leukemia also listed as an associated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED